同和药业
(300636)
| 流通市值:22.04亿 | | | 总市值:25.20亿 |
| 流通股本:3.67亿 | | | 总股本:4.20亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 608,217,884.31 | 383,163,489.97 | 184,392,671.37 | 828,659,350.98 |
| 营业总成本 | 562,366,220.33 | 357,376,905.98 | 167,876,632.18 | 702,520,673.31 |
| 其他经营收益 | | | | |
| 营业利润 | 33,396,256.69 | 20,080,426.04 | 19,615,993.9 | 74,894,385.22 |
| 利润总额 | 33,923,321.36 | 20,577,856.3 | 19,615,993.9 | 75,576,727.44 |
| 净利润 | 38,457,282.86 | 24,570,982.63 | 18,779,502.71 | 73,091,433.31 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 38,457,282.86 | 24,570,982.63 | 18,779,502.71 | 73,091,433.31 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,051,165,386.46 | 1,298,219,464.85 | 1,433,803,022.48 | 1,461,727,700.92 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,876,721,461.12 | 1,880,361,088.44 | 1,877,817,922.38 | 1,859,305,914.44 |
| 资产总计 | 2,927,886,847.58 | 3,178,580,553.29 | 3,311,620,944.86 | 3,321,033,615.36 |
| 流动负债: | | | | |
| 流动负债合计 | 396,273,886.92 | 673,186,757.07 | 787,920,144.82 | 666,921,271.86 |
| 非流动负债: | | | | |
| 非流动负债合计 | 144,719,090.01 | 132,386,225.8 | 139,686,649.74 | 288,877,695.91 |
| 负债合计 | 540,992,976.93 | 805,572,982.87 | 927,606,794.56 | 955,798,967.77 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,386,893,870.65 | 2,373,007,570.42 | 2,384,014,150.3 | 2,365,234,647.59 |
| 股东权益合计 | 2,386,893,870.65 | 2,373,007,570.42 | 2,384,014,150.3 | 2,365,234,647.59 |
| 负债和股东权益合计 | 2,927,886,847.58 | 3,178,580,553.29 | 3,311,620,944.86 | 3,321,033,615.36 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 634,761,415.8 | 403,830,605.75 | 194,284,667.55 | 830,137,521.27 |
| 经营活动现金流出小计 | 472,549,827.19 | 312,708,929.83 | 171,822,012.65 | 628,066,783.76 |
| 经营活动产生的现金流量净额 | 162,211,588.61 | 91,121,675.92 | 22,462,654.9 | 202,070,737.51 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 868,301,428.25 | 454,872,959.17 | 164,277,519.35 | 600,038,022.72 |
| 投资活动现金流出小计 | 659,392,606.15 | 410,632,134.62 | 298,197,822.39 | 616,946,774.65 |
| 投资活动产生的现金流量净额 | 208,908,822.1 | 44,240,824.55 | -133,920,303.04 | -16,908,751.93 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 228,149,653 | 122,997,053 | 59,712,000 | 469,890,512.13 |
| 筹资活动现金流出小计 | 706,825,639.72 | 328,554,751.16 | 86,664,175.71 | 567,855,028.09 |
| 筹资活动产生的现金流量净额 | -478,675,986.72 | -205,557,698.16 | -26,952,175.71 | -97,964,515.96 |
| 汇率变动对现金及现金等价物的影响 | -8,156,247.95 | -6,535,543.07 | -4,187,012.02 | 233,576.1 |
| 现金及现金等价物净增加额 | -115,711,823.96 | -76,730,740.76 | -142,596,835.87 | 87,431,045.72 |
| 期末现金及现金等价物余额 | 137,131,459.52 | 176,112,542.72 | 110,246,447.61 | 252,843,283.48 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -76,730,740.76 | - | 87,431,045.72 |
最新报告期:2026-09-08| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中泰证券 | 祝嘉琦 | 0.12 | 0.20 | 0.26 | 2026-09-08 |
| 华创证券 | 郑辰,王宏雨 | 0.21 | 0.26 | 0.31 | 2026-09-04 |